GlassScriptPhysician profile
Robert Paul Cope
NPI 1316473424
$12,537.19
in general payments reported to CMS, 2019-2025
27 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,103 · 2020: $1,003 · 2021: $908 · 2022: $2,925 · 2023: $2,596 · 2024: $2,655 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,231 · Food and Beverage: $2,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,230.88 |
| Food and Beverage | $2,368.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $3,637.57 | 2022-2024 | Creo 5.5, Excelsiusgps Robotic Navigation System, Elsa |
| Stryker Corporation | $2,112.51 | 2019-2023 | Avs Navigator, Mako |
| Medacta USA, INC. | $2,011.29 | 2024-2025 | Myspine, Mecta-C |
| Medtronic, INC. | $1,223.26 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Zimmer Biomet Holdings, INC. | $721.36 | 2019-2021 | |
| Pinnacle, INC | $617.04 | 2019 | |
| Cerapedics INC. | $550.05 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Medical Device Business Services, INC. | $399.98 | 2019-2021 | |
| Depuy Synthes Sales INC. | $183.64 | 2019-2023 | Skyline |
| Smith+Nephew, INC. | $146.80 | 2021 | |
| Medtronic USA, INC. | $122.25 | 2020 | |
| Carlsmed, INC. | $102.13 | 2024 | Aprevo |
| Baxter Healthcare | $101.41 | 2019-2020 | |
| Ortho Development Corporation | $95.28 | 2021 | |
| Providence Medical Technology, INC. | $83.34 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $70.23 | 2024-2025 | Spinal-Stim |
| Boston Scientific Corporation | $59.30 | 2023 | Wavewriter Alpha Prime 16 |
| Trackx Technology, INC. | $58.54 | 2024-2025 | |
| Augmedics INC. | $47.80 | 2024-2025 | Xvision |
| Conformis, INC. | $46.06 | 2021 | |
| Pfizer INC. | $28.44 | 2025 | |
| Theragen, INC. | $25.46 | 2024 | Actastim-S |
| Heron Therapeutics, INC. | $24.07 | 2023 | Zynrelef |
| Spineology INC. | $21.89 | 2025 | |
| Nevro Corp. | $18.05 | 2023 | Senza |
| Nanohive Medical LLC | $15.50 | 2025 | Hive C, Csa, Alif, Tlif |
| Ethicon US, LLC | $13.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.